Latest On Alimera Sciences, Inc (ALIM):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-18 16:47 EST | News | Alimera jumps 48% on deal with EyePoint for eye disorder therapy Yutiq | N/A |  |
| 2023-05-15 20:39 EST | News | Alimera Sciences GAAP EPS of -$0.71 misses by $0.19, revenue of $13.55M beats by $1.25M | N/A | |
| 2023-04-03 17:08 EST | News | Alimera expands distribution pact for eye drug implant Iluvien to Nordic region | N/A | |
| 2023-03-31 16:50 EST | News | Alimera Sciences GAAP EPS of -$0.54 misses by $0.20, revenue of $14.03M misses by $0.59M | N/A | |
| 2023-03-31 16:50 EST | News | Alimera Sciences, Inc. (ALIM) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-31 00:49 EST | News | Alimera Sciences Q4 2022 Earnings Preview | N/A | |
| 2023-02-22 09:46 EST | News | Alimera's partner files for approval of eye implant therapy Iluvien in Switzerland | N/A | |
| 2022-11-14 22:09 EST | News | Alimera Sciences GAAP EPS of -$0.75 misses by $0.35, revenue of $13.6M misses by $1.45M | N/A | |
| 2022-11-14 22:08 EST | News | Alimera Sciences, Inc. (ALIM) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-12 00:39 EST | News | Alimera Sciences Q3 2022 Earnings Preview | N/A | |
| 2022-10-06 22:49 EST | News | Alimera confirmatory trial testing Iluvien in diabetic macular edema patients shows positive data | N/A | |
| 2022-09-20 12:06 EST | News | Alimera's eye inflammation Iluvien injection granted reimbursement in Ireland | N/A | |
| 2022-08-09 18:15 EST | News | Alimera granted reimbursement in Portugal for eye inflammation Iluvien injection | N/A | |
| 2022-07-30 13:46 EST | News | Alimera Sciences, Inc. (ALIM) CEO Rick Eiswirth on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-07-27 15:36 EST | News | Alimera Sciences reports Q2 results | N/A | |
| 2022-07-22 11:41 EST | News | Alimera granted pricing, reimbursement in France for eye inflammation Iluvien injection | N/A | |
| 2022-07-08 14:52 EST | News | Alimera gets Italian nod for its Iluvien injection to treat a form of eye inflammation | N/A | |
| 2022-06-08 15:04 EST | News | Alimera's partner Ocumension gets China regulator nod to start diabetic macular edema study | N/A | |
| 2022-05-10 01:38 EST | News | Alimera Sciences GAAP EPS of -$0.85 misses by $0.16, revenue of $11.89M misses by $1.01M | N/A | |
| 2022-05-10 01:38 EST | News | Alimera Sciences, Inc (ALIM) CEO Richard Eiswirth on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-02-25 04:07 EST | News | Alimera Sciences, Inc (ALIM) CEO Richard Eiswirth on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-24 08:20 EST | News | Alimera Sciences GAAP EPS of -$0.59 misses by $0.17, revenue of $13.95M beats by $0.55M | N/A | |
| 2022-02-23 12:21 EST | News | Alimera's 3-year data for ILUVIEN shows benefit in diabetic macular edema | N/A | |
| 2022-02-23 12:21 EST | News | Alimera Sciences Q4 2021 Earnings Preview | N/A | |
| 2021-10-28 16:20 EST | News | Alimera Sciences EPS misses by $0.07, misses on revenue | N/A | |
| 2021-10-28 16:20 EST | News | Alimera Sciences, Inc. (ALIM) CEO Richard Eiswirth on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-10-13 16:44 EST | News | Alimera posts real world data to show benefits of ILUVIEN in Diabetic Macular Edema | N/A | |
| 2021-10-12 20:00 EST | News | Warning: ALIM is at high risk of performing badly | N/A | |
| 2021-10-07 04:05 EST | News | ALIM is at high risk of performing badly | N/A | |
| 2021-09-27 12:15 EST | News | Warning: ALIM has been downgraded to Very Bearish | N/A | |
| 2021-09-21 11:22 EST | News | Warning: ALIM has been downgraded to Very Bearish. | N/A | |
| 2021-08-14 04:56 EST | News | Alimera Sciences' (ALIM) CEO Rick Eiswirth on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-13 08:26 EST | News | Alimera Sciences Q2 2021 Earnings Preview | N/A | |
| 2021-08-13 08:25 EST | News | Alimera Sciences EPS misses by $0.03, beats on revenue | N/A | |
| 2021-05-01 23:41 EST | News | Alimera Sciences Inc. (ALIM) CEO Rick Eiswirth on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-04-29 06:54 EST | News | Alimera Sciences EPS misses by $0.09, misses on revenue | N/A | |
| 2021-04-14 21:10 EST | News | Alimera Sciences receives $20M from Ocumension Therapeutics | N/A | |
| 2021-03-17 18:11 EST | News | Alimera achieves private healthcare reimbursement for Iluvien in Ireland | N/A | |
| 2021-03-02 11:04 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-28 23:04 EST | Analyst Rating | The Analyst Target Price has increased from $13.5 to $14.25. | Buy | |
| 2021-02-28 01:23 EST | News | Alimera Sciences, Inc. (ALIM) CEO Rick Eiswirth on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-27 11:04 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-25 11:06 EST | Earnings Estimate | An EPS average of $1.80 is estimated for the 2022 year. | Buy | |
| 2021-02-25 11:06 EST | Earnings Estimate | An EPS average of -$0.19 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-02-24 21:44 EST | News | Alimera Sciences EPS misses by $0.16, beats on revenue | N/A | |
| 2021-01-19 23:49 EST | News | Alimera Sciences +14%, provides preliminary Q4 and FY numbers | N/A | |
| 2020-12-19 01:07 EST | News | EyePoint Pharma reports $16.5M monetization of Iluvien royalty with SWK Holdings | N/A | |
| 2020-12-13 03:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-11 15:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-25 11:10 EST | Financials | Company financials have been released. | Neutral | |
About Alimera Sciences, Inc (ALIM):
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
General
- Name Alimera Sciences, Inc
- Symbol ALIM
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 130
- Last Split Factor1:15
- Last Split Date2019-11-15
- Fiscal Year EndDecember
- IPO Date2010-04-22
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.alimerasciences.com
View More
Valuation
- Forward PE 60.61
- Price/Sales (Trailing 12 Mt.) 1.1
- Enterprise Value Revenue 2.25
- Enterprise Value EBITDA 43.18
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.12
- Next Year EPS Estimate $0.81
- Next Quarter EPS Estimate -$0.08
- Profit Margin -11%
- Operating Margin -2%
- Return on Assets -1%
- Revenue 50.82 million
- Earnings Per Share $0.30
- Revenue Per Share $9.93
- Gross Profit 43.88 million
- Quarterly Earnings Growth -20.6%
View More
Highlights
- Market Capitalization 62.14 million
- EBITDA 1.78 million
- Analyst Target Price $14.25
- Book Value Per Share -$0.48
View More
Share Statistics
- Shares Outstanding 5.75 million
- Shares Float 4.5 million
- % Held by Insiders 1635%
- % Held by Institutions 40.26%
- Shares Short 135864
- Shares Short Prior Month 138171
- Short Ratio 1.31
- Short % of Float 3%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 1.66
- 52 Week High $11.5
- 52 Week Low $2.92
- 50 Day Moving Average 8.56
- 200 Day Moving Average 5.89
View More
Dividends
- Dividend Date 2019-11-15
- ExDividend Date N/A
- Dividend Yield 0%
View More
Alimera Sciences, Inc (ALIM) Dividend Calendar:
ALIM's last dividend payment was made to shareholders on November 15, 2019.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Alimera Sciences, Inc (ALIM) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-24 | $N/A | -$0.21 | -$0.14 | -56.15% |
| 2020-09-30 | 2020-10-28 | $N/A | -$0.17 | -$0.29 | 39.1% |
| 2020-06-30 | 2020-07-29 | $N/A | -$0.53 | -$1.25 | 57.78% |
| 2020-03-31 | 2020-04-29 | $N/A | -$0.22 | -$0.46 | 50.7% |
| 2019-12-31 | 2020-02-26 | $17.35 million | $0.07 | -$0.29 | 124.86% |
| 2019-09-30 | 2019-10-29 | $12.85 million | -$0.63 | -$0.55 | -15.36% |
| 2019-06-30 | 2019-07-29 | $10.86 million | -$1.04 | -$0.50 | -107.6% |
| 2019-03-31 | 2019-04-29 | $12.89 million | -$0.57 | -$0.63 | 9.33% |
| 2018-12-31 | 2019-02-19 | $15.11 million | -$0.12 | -$0.45 | 74% |
| 2018-09-30 | 2018-11-06 | $11.14 million | -$0.59 | -$0.94 | 37.6% |
| 2018-06-30 | 2018-07-30 | $10.92 million | -$0.85 | -$0.98 | 12.77% |
| 2018-03-31 | 2018-05-03 | $9.8 million | -$1.20 | -$0.53 | -128.57% |
| 2017-12-31 | 2018-02-28 | $9.14 million | -$1.57 | -$0.65 | -141.62% |
| 2017-09-30 | 2017-11-01 | $9.78 million | -$1.78 | -$0.65 | -174.15% |
| 2017-06-30 | 2017-08-02 | $10.37 million | -$0.64 | -$0.95 | 32.26% |
| 2017-03-31 | 2017-05-08 | $6.62 million | -$1.50 | -$1.50 | 0% |
| 2016-12-31 | 2017-03-01 | $10.68 million | -$1.50 | -$1.35 | -11.11% |
| 2016-09-30 | 2016-11-02 | $8.3 million | -$2.30 | -$1.65 | -39.45% |
| 2016-06-30 | 2016-08-03 | $9.56 million | -$2.55 | -$2.48 | -3.03% |
| 2016-03-31 | 2016-05-04 | $5.8 million | -$3.30 | -$2.85 | -15.79% |
| 2015-12-31 | 2016-03-03 | $5.82 million | -$3.60 | -$3.50 | -2.86% |
| 2015-09-30 | 2015-11-05 | $6.9 million | -$0.03 | -$0.21 | 85.71% |
| 2015-06-30 | 2015-08-10 | $5.78 million | -$0.19 | -$0.22 | 13.64% |
| 2015-03-31 | 2015-05-07 | $3.94 million | -$0.22 | -$0.24 | 8.33% |
| 2014-12-31 | 2015-03-04 | $1.74 million | -$0.23 | -$0.17 | -35.29% |
| 2014-09-30 | 2014-11-06 | $2.41 million | -$0.17 | -$0.70 | 75.71% |
| 2014-06-30 | 2014-08-07 | $2.19 million | $0.60 | -$3.37 | 117.8% |
| 2014-03-31 | 2014-05-08 | $2.08 million | -$3.00 | -$3.67 | 18.26% |
| 2013-12-31 | 2014-02-27 | $935000 | -$6.30 | -$4.28 | -47.2% |
| 2013-09-30 | 2013-11-11 | $758000 | -$3.90 | -$4.42 | 11.76% |
| 2013-06-30 | 2013-08-12 | $179000 | -$4.50 | -$3.60 | -25% |
| 2013-03-31 | 2013-05-09 | $N/A | -$4.05 | -$3.97 | -2.02% |
| 2012-12-31 | 2013-03-21 | $N/A | -$2.55 | -$3.45 | 26.09% |
| 2012-09-30 | 2012-11-07 | $N/A | -$2.55 | -$2.70 | 5.56% |
| 2012-06-30 | 2012-08-09 | $N/A | -$2.25 | -$2.44 | 7.79% |
| 2012-03-31 | 2012-05-11 | $N/A | -$2.10 | -$1.86 | -12.9% |
| 2011-12-31 | 2012-03-08 | $N/A | -$2.85 | -$3.34 | 14.67% |
| 2011-09-30 | 2011-11-03 | $N/A | -$3.15 | -$2.85 | -10.53% |
| 2011-06-30 | 2011-08-04 | $N/A | -$2.55 | -$2.91 | 12.37% |
| 2011-03-31 | 2011-05-05 | $N/A | -$2.25 | -$2.92 | 22.95% |
| 2010-12-31 | 2011-02-10 | $N/A | -$3.00 | -$3.34 | 10.18% |
| 2010-09-30 | 2010-11-04 | $N/A | -$3.00 | -$3.94 | 23.86% |
| 2010-06-30 | 2010-08-12 | $N/A | -$4.05 | -$3.94 | -2.79% |
| 2010-03-31 | 2010-06-03 | $N/A | -$65.55 | -$7.35 | -791.84% |
Alimera Sciences, Inc (ALIM) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Alimera Sciences, Inc (ALIM) Chart:
Alimera Sciences, Inc (ALIM) News:
Below you will find a list of latest news for Alimera Sciences, Inc (ALIM) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Alimera Sciences, Inc (ALIM) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-04-17 | 2.5 | 0 | CALL | 0 | 0 | 660.89 | TRUE | 0 | 0 |
| 2025-04-17 | 5 | 0.5 | CALL | 0 | 53 | 0 | TRUE | 0 | 0 |
| 2025-04-17 | 7.5 | 0.03 | CALL | 0 | 240 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 10 | 0.05 | CALL | 0 | 20 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 2.5 | 0.05 | PUT | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 5 | 0.05 | PUT | 0 | 4154 | 16 | FALSE | 0 | 0 |
| 2025-04-17 | 7.5 | 2.05 | PUT | 0 | 43 | 39.67 | TRUE | 0 | 0 |
| 2025-04-17 | 10 | 4.8 | PUT | 0 | 1 | 59.81 | TRUE | 0 | 0 |
Alimera Sciences, Inc (ALIM) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000100/0001267602-20-000100-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000090266419001015/0000902664-19-001015-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000090266420001114/0000902664-20-001114-index.htm |
| 2019-06-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000090445419000515/0000904454-19-000515-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000090445420000413/0000904454-20-000413-index.htm |
| 2020-09-29 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1267602/000090445420000636/0000904454-20-000636-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000091957419001731/0000919574-19-001731-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000091957420001599/0000919574-20-001599-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000093583619000096/0000935836-19-000096-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000093583619000107/0000935836-19-000107-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000093583620000106/0000935836-20-000106-index.htm |
| 2020-08-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1267602/000094280120000005/0000942801-20-000005-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000110465919008752/0001104659-19-008752-index.htm |
| 2019-11-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000110465919058965/0001104659-19-058965-index.htm |
| 2019-12-11 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1267602/000110465919071699/0001104659-19-071699-index.htm |
| 2020-01-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1267602/000110465920006592/0001104659-20-006592-index.htm |
| 2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000110465920016248/0001104659-20-016248-index.htm |
| 2019-02-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1267602/000119312519039128/0001193125-19-039128-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000119312519041151/0001193125-19-041151-index.htm |
| 2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000119312520030598/0001193125-20-030598-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000119380519000185/0001193805-19-000185-index.htm |
| 2020-01-23 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000119380520000056/0001193805-20-000056-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000026/0001267602-19-000026-index.htm |
| 2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000029/0001267602-19-000029-index.htm |
| 2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000030/0001267602-19-000030-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000032/0001267602-19-000032-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000035/0001267602-19-000035-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000037/0001267602-19-000037-index.htm |
| 2019-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000039/0001267602-19-000039-index.htm |
| 2019-02-25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000043/0001267602-19-000043-index.htm |
| 2019-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000045/0001267602-19-000045-index.htm |
| 2019-03-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000047/0001267602-19-000047-index.htm |
| 2019-03-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000050/0001267602-19-000050-index.htm |
| 2019-04-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000052/0001267602-19-000052-index.htm |
| 2019-04-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000054/0001267602-19-000054-index.htm |
| 2019-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000058/0001267602-19-000058-index.htm |
| 2019-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000060/0001267602-19-000060-index.htm |
| 2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000063/0001267602-19-000063-index.htm |
| 2019-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000067/0001267602-19-000067-index.htm |
| 2019-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000070/0001267602-19-000070-index.htm |
| 2019-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000071/0001267602-19-000071-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000075/0001267602-19-000075-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000077/0001267602-19-000077-index.htm |
| 2019-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000079/0001267602-19-000079-index.htm |
| 2019-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000083/0001267602-19-000083-index.htm |
| 2019-06-20 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000085/0001267602-19-000085-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000087/0001267602-19-000087-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000092/0001267602-19-000092-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000093/0001267602-19-000093-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000094/0001267602-19-000094-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000095/0001267602-19-000095-index.htm |
| 2019-07-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000097/0001267602-19-000097-index.htm |
| 2019-07-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000099/0001267602-19-000099-index.htm |
| 2019-07-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000101/0001267602-19-000101-index.htm |
| 2019-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000103/0001267602-19-000103-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000106/0001267602-19-000106-index.htm |
| 2019-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000109/0001267602-19-000109-index.htm |
| 2019-09-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000111/0001267602-19-000111-index.htm |
| 2019-09-16 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000113/0001267602-19-000113-index.htm |
| 2019-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000117/0001267602-19-000117-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000122/0001267602-19-000122-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000123/0001267602-19-000123-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000124/0001267602-19-000124-index.htm |
| 2019-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000125/0001267602-19-000125-index.htm |
| 2019-09-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000127/0001267602-19-000127-index.htm |
| 2019-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000134/0001267602-19-000134-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000136/0001267602-19-000136-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000138/0001267602-19-000138-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000140/0001267602-19-000140-index.htm |
| 2019-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000142/0001267602-19-000142-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000147/0001267602-19-000147-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000148/0001267602-19-000148-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000149/0001267602-19-000149-index.htm |
| 2019-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000150/0001267602-19-000150-index.htm |
| 2019-10-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000153/0001267602-19-000153-index.htm |
| 2019-10-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000155/0001267602-19-000155-index.htm |
| 2019-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000157/0001267602-19-000157-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000162/0001267602-19-000162-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000163/0001267602-19-000163-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000164/0001267602-19-000164-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000165/0001267602-19-000165-index.htm |
| 2019-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000167/0001267602-19-000167-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000169/0001267602-19-000169-index.htm |
| 2019-11-07 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000171/0001267602-19-000171-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000173/0001267602-19-000173-index.htm |
| 2019-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000175/0001267602-19-000175-index.htm |
| 2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000178/0001267602-19-000178-index.htm |
| 2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000180/0001267602-19-000180-index.htm |
| 2019-11-19 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000187/0001267602-19-000187-index.htm |
| 2019-11-19 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000188/0001267602-19-000188-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000189/0001267602-19-000189-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000190/0001267602-19-000190-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000191/0001267602-19-000191-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000192/0001267602-19-000192-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000194/0001267602-19-000194-index.htm |
| 2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000196/0001267602-19-000196-index.htm |
| 2019-12-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000201/0001267602-19-000201-index.htm |
| 2019-12-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000202/0001267602-19-000202-index.htm |
| 2019-12-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000203/0001267602-19-000203-index.htm |
| 2019-12-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000204/0001267602-19-000204-index.htm |
| 2019-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000206/0001267602-19-000206-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000211/0001267602-19-000211-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000212/0001267602-19-000212-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000213/0001267602-19-000213-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000214/0001267602-19-000214-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000005/0001267602-20-000005-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000006/0001267602-20-000006-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000007/0001267602-20-000007-index.htm |
| 2020-01-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000008/0001267602-20-000008-index.htm |
| 2020-01-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000011/0001267602-20-000011-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000017/0001267602-20-000017-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000018/0001267602-20-000018-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000019/0001267602-20-000019-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000020/0001267602-20-000020-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000021/0001267602-20-000021-index.htm |
| 2020-02-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000025/0001267602-20-000025-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000027/0001267602-20-000027-index.htm |
| 2020-03-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000029/0001267602-20-000029-index.htm |
| 2020-03-03 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000033/0001267602-20-000033-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000034/0001267602-20-000034-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000035/0001267602-20-000035-index.htm |
| 2020-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000037/0001267602-20-000037-index.htm |
| 2020-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000039/0001267602-20-000039-index.htm |
| 2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000041/0001267602-20-000041-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000043/0001267602-20-000043-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000050/0001267602-20-000050-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000051/0001267602-20-000051-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000052/0001267602-20-000052-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000053/0001267602-20-000053-index.htm |
| 2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000054/0001267602-20-000054-index.htm |
| 2020-04-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000056/0001267602-20-000056-index.htm |
| 2020-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000058/0001267602-20-000058-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000063/0001267602-20-000063-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000064/0001267602-20-000064-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000068/0001267602-20-000068-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000075/0001267602-20-000075-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000076/0001267602-20-000076-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000077/0001267602-20-000077-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000079/0001267602-20-000079-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000083/0001267602-20-000083-index.htm |
| 2020-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000085/0001267602-20-000085-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000093/0001267602-20-000093-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000094/0001267602-20-000094-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000095/0001267602-20-000095-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000096/0001267602-20-000096-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000097/0001267602-20-000097-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000100/0001267602-20-000100-index.htm |
| 2020-07-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000102/0001267602-20-000102-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000107/0001267602-20-000107-index.htm |
| 2020-08-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000109/0001267602-20-000109-index.htm |
| 2020-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000111/0001267602-20-000111-index.htm |
| 2020-11-02 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000113/0001267602-20-000113-index.htm |
| 2020-11-03 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000116/0001267602-20-000116-index.htm |
| 2020-11-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000118/0001267602-20-000118-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000130692319000002/0001306923-19-000002-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000130692320000006/0001306923-20-000006-index.htm |
| 2019-11-20 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000138713119008898/0001387131-19-008898-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1267602/000138713120001568/0001387131-20-001568-index.htm |
| 2019-09-17 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000147450619000177/0001474506-19-000177-index.htm |
| 2019-09-17 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000147450619000178/0001474506-19-000178-index.htm |
| 2019-09-17 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000147450619000179/0001474506-19-000179-index.htm |
| 2019-09-17 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000147450619000180/0001474506-19-000180-index.htm |
| 2019-09-17 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000147450619000181/0001474506-19-000181-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000147450620000239/0001474506-20-000239-index.htm |
| 2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000147450620000291/0001474506-20-000291-index.htm |
| 2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000147450620000292/0001474506-20-000292-index.htm |
| 2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000147450620000293/0001474506-20-000293-index.htm |
| 2020-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000147450620000294/0001474506-20-000294-index.htm |
| 2020-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000147450620000295/0001474506-20-000295-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1267602/000176200719000005/0001762007-19-000005-index.htm |
| 2020-02-19 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1267602/999999999720000801/9999999997-20-000801-index.htm |
| 2020-01-31 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1267602/999999999720001253/9999999997-20-001253-index.htm |
Alimera Sciences, Inc (ALIM) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alimera Sciences, Inc (ALIM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1635%Institutional Ownership: 4026%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-11-21 | John Snisarenko | Director | Buy | 10,000.00 | 4.95 | 49,500.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000196/0001267602-19-000196-index.htm |
| 2020-03-18 | Philip Ashman | Chief Operating Officer & SVP | Buy | 5,389.00 | 10,641.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000054/0001267602-20-000054-index.htm | ||
| 2019-09-13 | John Philip Jones | Chief Financial Officer | Buy | 1,454.00 | 0.41 | 596.14 | 107,450.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000122/0001267602-19-000122-index.htm |
| 2019-09-30 | John Philip Jones | Chief Financial Officer | Buy | 1,046.00 | 0.57 | 596.22 | 108,496.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000136/0001267602-19-000136-index.htm |
| 2019-01-23 | John Philip Jones | Chief Financial Officer | Buy | 79,400.00 | 108,596.00 | https://www.sec.gov/Archives/edgar/data/1267602/000176200719000005/0001762007-19-000005-index.htm | ||
| 2019-10-15 | John Philip Jones | Chief Financial Officer | Buy | 1,490.00 | 0.40 | 596.00 | 109,986.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000149/0001267602-19-000149-index.htm |
| 2019-04-30 | John Philip Jones | Chief Financial Officer | Buy | 1,633.00 | 0.82 | 1,346.41 | 110,229.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000070/0001267602-19-000070-index.htm |
| 2019-10-31 | John Philip Jones | Chief Financial Officer | Buy | 2,104.00 | 0.28 | 596.27 | 112,090.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000164/0001267602-19-000164-index.htm |
| 2019-10-31 | John Philip Jones | Chief Financial Officer | Buy | 2,500.00 | 0.24 | 602.25 | 114,590.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000164/0001267602-19-000164-index.htm |
| 2020-03-18 | John Philip Jones | Chief Financial Officer | Buy | 3,958.00 | 11,768.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000053/0001267602-20-000053-index.htm | ||
| 2020-04-30 | John Philip Jones | Chief Financial Officer | Buy | 167.00 | 3.61 | 603.40 | 11,935.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000075/0001267602-20-000075-index.htm |
| 2020-11-04 | Philip Ashman | Chief Operating Officer & SVP | Buy | 1,316.00 | 4.50 | 5,921.87 | 11,957.00 | https://www.sec.gov/Archives/edgar/data/1267602/000147450620000295/0001474506-20-000295-index.htm |
| 2020-10-30 | John Philip Jones | Chief Financial Officer | Buy | 421.00 | 3.56 | 1,499.39 | 12,356.00 | https://www.sec.gov/Archives/edgar/data/1267602/000147450620000293/0001474506-20-000293-index.htm |
| 2019-11-01 | John Philip Jones | Chief Financial Officer | Buy | 10,000.00 | 0.30 | 3,008.00 | 124,590.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000164/0001267602-19-000164-index.htm |
| 2019-11-15 | David Holland | Chief Marketing Officer & SVP | Buy | 170.00 | 4.75 | 807.50 | 17,795.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000191/0001267602-19-000191-index.htm |
| 2019-11-29 | David Holland | Chief Marketing Officer & SVP | Buy | 142.00 | 5.66 | 803.72 | 17,937.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000203/0001267602-19-000203-index.htm |
| 2019-12-13 | David Holland | Chief Marketing Officer & SVP | Buy | 98.00 | 8.24 | 807.52 | 18,035.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000213/0001267602-19-000213-index.htm |
| 2019-12-31 | David Holland | Chief Marketing Officer & SVP | Buy | 106.00 | 7.58 | 803.48 | 18,141.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000005/0001267602-20-000005-index.htm |
| 2020-03-18 | David Holland | Chief Marketing Officer & SVP | Buy | 5,172.00 | 20,773.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000051/0001267602-20-000051-index.htm | ||
| 2020-04-30 | David Holland | Chief Marketing Officer & SVP | Buy | 167.00 | 3.61 | 603.40 | 20,940.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000077/0001267602-20-000077-index.htm |
| 2020-10-30 | David Holland | Chief Marketing Officer & SVP | Buy | 500.00 | 3.56 | 1,780.75 | 21,440.00 | https://www.sec.gov/Archives/edgar/data/1267602/000147450620000292/0001474506-20-000292-index.htm |
| 2019-09-13 | David Holland | Chief Marketing Officer & SVP | Buy | 1,970.00 | 0.41 | 807.70 | 255,592.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000124/0001267602-19-000124-index.htm |
| 2019-09-30 | David Holland | Chief Marketing Officer & SVP | Buy | 1,417.00 | 0.57 | 807.69 | 257,009.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000142/0001267602-19-000142-index.htm |
| 2019-10-15 | David Holland | Chief Marketing Officer & SVP | Buy | 2,020.00 | 0.40 | 808.00 | 259,029.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000150/0001267602-19-000150-index.htm |
| 2019-10-31 | David Holland | Chief Marketing Officer & SVP | Buy | 2,850.00 | 0.28 | 807.69 | 261,879.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000163/0001267602-19-000163-index.htm |
| 2019-10-31 | David Holland | Chief Marketing Officer & SVP | Buy | 2,500.00 | 0.24 | 602.25 | 264,379.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000163/0001267602-19-000163-index.htm |
| 2019-11-19 | James R Largent | Director | Buy | 3,000.00 | 5.11 | 15,344.10 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000194/0001267602-19-000194-index.htm |
| 2019-11-15 | RICHARD S JR EISWIRTH | President and CEO | Buy | 323.00 | 4.75 | 1,534.25 | 31,249.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000189/0001267602-19-000189-index.htm |
| 2019-11-29 | RICHARD S JR EISWIRTH | President and CEO | Buy | 271.00 | 5.66 | 1,533.86 | 31,520.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000204/0001267602-19-000204-index.htm |
| 2019-12-13 | RICHARD S JR EISWIRTH | President and CEO | Buy | 186.00 | 8.24 | 1,532.64 | 31,706.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000211/0001267602-19-000211-index.htm |
| 2019-12-31 | RICHARD S JR EISWIRTH | President and CEO | Buy | 202.00 | 7.58 | 1,531.16 | 31,908.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000007/0001267602-20-000007-index.htm |
| 2019-04-30 | RICHARD S JR EISWIRTH | President and CEO | Buy | 2,500.00 | 0.82 | 2,061.25 | 345,704.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000071/0001267602-19-000071-index.htm |
| 2019-09-13 | RICHARD S JR EISWIRTH | President and CEO | Buy | 3,745.00 | 0.41 | 1,535.45 | 349,449.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000123/0001267602-19-000123-index.htm |
| 2019-09-30 | RICHARD S JR EISWIRTH | President and CEO | Buy | 2,694.00 | 0.57 | 1,535.58 | 352,143.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000138/0001267602-19-000138-index.htm |
| 2019-10-15 | RICHARD S JR EISWIRTH | President and CEO | Buy | 3,839.00 | 0.40 | 1,535.60 | 355,982.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000148/0001267602-19-000148-index.htm |
| 2019-10-31 | RICHARD S JR EISWIRTH | President and CEO | Buy | 5,419.00 | 0.28 | 1,535.74 | 361,401.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000162/0001267602-19-000162-index.htm |
| 2019-10-31 | RICHARD S JR EISWIRTH | President and CEO | Buy | 2,500.00 | 0.24 | 602.25 | 363,901.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000162/0001267602-19-000162-index.htm |
| 2020-03-18 | RICHARD S JR EISWIRTH | President and CEO | Buy | 10,884.00 | 38,876.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000052/0001267602-20-000052-index.htm | ||
| 2020-04-30 | RICHARD S JR EISWIRTH | President and CEO | Buy | 167.00 | 3.61 | 603.40 | 39,043.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000076/0001267602-20-000076-index.htm |
| 2020-10-30 | RICHARD S JR EISWIRTH | President and CEO | Buy | 500.00 | 3.56 | 1,780.75 | 39,543.00 | https://www.sec.gov/Archives/edgar/data/1267602/000147450620000291/0001474506-20-000291-index.htm |
| 2020-11-02 | RICHARD S JR EISWIRTH | President and CEO | Buy | 2,500.00 | 4.15 | 10,377.00 | 42,043.00 | https://www.sec.gov/Archives/edgar/data/1267602/000147450620000294/0001474506-20-000294-index.htm |
| 2019-11-14 | RICHARD S JR EISWIRTH | President and CEO | Buy | 75,000.00 | 0.30 | 22,417.50 | 438,901.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000180/0001267602-19-000180-index.htm |
| 2019-11-14 | RICHARD S JR EISWIRTH | President and CEO | Buy | 25,000.00 | 0.30 | 7,472.50 | 463,901.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000180/0001267602-19-000180-index.htm |
| 2019-11-15 | Samer Kaba | Chief Medical Officer | Buy | 149.00 | 4.75 | 707.75 | 5,367.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000192/0001267602-19-000192-index.htm |
| 2019-11-29 | Samer Kaba | Chief Medical Officer | Buy | 126.00 | 5.66 | 713.16 | 5,493.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000202/0001267602-19-000202-index.htm |
| 2020-08-20 | C. Daniel Myers | Director | Sell | 5,000.00 | 6.73 | 33,650.00 | 5,578.00 | https://www.sec.gov/Archives/edgar/data/1267602/000147450620000239/0001474506-20-000239-index.htm |
| 2019-12-13 | Samer Kaba | Chief Medical Officer | Buy | 86.00 | 8.24 | 708.64 | 5,579.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000212/0001267602-19-000212-index.htm |
| 2019-12-31 | Samer Kaba | Chief Medical Officer | Buy | 93.00 | 7.58 | 704.94 | 5,672.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000006/0001267602-20-000006-index.htm |
| 2019-09-13 | Samer Kaba | Chief Medical Officer | Buy | 1,736.00 | 0.41 | 711.76 | 72,736.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000125/0001267602-19-000125-index.htm |
| 2019-09-30 | Samer Kaba | Chief Medical Officer | Buy | 1,249.00 | 0.57 | 711.93 | 73,985.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000140/0001267602-19-000140-index.htm |
| 2019-10-15 | Samer Kaba | Chief Medical Officer | Buy | 1,779.00 | 0.40 | 711.60 | 75,764.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000147/0001267602-19-000147-index.htm |
| 2019-10-31 | Samer Kaba | Chief Medical Officer | Buy | 2,513.00 | 0.28 | 712.18 | 78,277.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000165/0001267602-19-000165-index.htm |
| 2019-11-15 | John Philip Jones | Chief Financial Officer | Buy | 125.00 | 4.75 | 593.75 | 8,431.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000190/0001267602-19-000190-index.htm |
| 2019-11-29 | John Philip Jones | Chief Financial Officer | Buy | 105.00 | 5.66 | 594.30 | 8,536.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000201/0001267602-19-000201-index.htm |
| 2020-03-18 | Samer Kaba | Chief Medical Officer | Buy | 4,683.00 | 8,679.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000050/0001267602-20-000050-index.htm | ||
| 2019-12-10 | John Philip Jones | Chief Financial Officer | Buy | 1,000.00 | 9.29 | 9,293.70 | 9,536.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000206/0001267602-19-000206-index.htm |
| 2019-12-13 | John Philip Jones | Chief Financial Officer | Buy | 72.00 | 8.24 | 593.28 | 9,608.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760219000214/0001267602-19-000214-index.htm |
| 2019-12-31 | John Philip Jones | Chief Financial Officer | Buy | 78.00 | 7.58 | 591.24 | 9,686.00 | https://www.sec.gov/Archives/edgar/data/1267602/000126760220000008/0001267602-20-000008-index.htm |